71 related articles for article (PubMed ID: 25497868)
1. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer.
Nagaraju GP; Zhu S; Ko JE; Ashritha N; Kandimalla R; Snyder JP; Shoji M; El-Rayes BF
Cancer Lett; 2015 Feb; 357(2):557-65. PubMed ID: 25497868
[TBL] [Abstract][Full Text] [Related]
2. Curcumin analog, GO-Y078, overcomes resistance to tumor angiogenesis inhibitors.
Shimazu K; Inoue M; Sugiyama S; Fukuda K; Yoshida T; Taguchi D; Uehara Y; Kuriyama S; Tanaka M; Miura M; Nanjyo H; Iwabuchi Y; Shibata H
Cancer Sci; 2018 Oct; 109(10):3285-3293. PubMed ID: 30024080
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
Jutooru I; Chadalapaka G; Lei P; Safe S
J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
[TBL] [Abstract][Full Text] [Related]
4. Effects of neratinib on angiogenesis and the early stage of the embryo using chicken embryo as a model.
Kheraldine H; Hassan AF; Alhussain H; Al-Thawadi H; Vranic S; Al Moustafa AE
Biomol Biomed; 2024 May; 24(3):575-581. PubMed ID: 38158791
[TBL] [Abstract][Full Text] [Related]
5. Targeting neovascularization and respiration of tumor grafts grown on chick embryo chorioallantoic membranes.
Ademi H; Shinde DA; Gassmann M; Gerst D; Chaachouay H; Vogel J; Gorr TA
PLoS One; 2021; 16(5):e0251765. PubMed ID: 33999935
[TBL] [Abstract][Full Text] [Related]
6. Angiopoietin-like 4 promotes angiogenesis in the tendon and is increased in cyclically loaded tendon fibroblasts.
Mousavizadeh R; Scott A; Lu A; Ardekani GS; Behzad H; Lundgreen K; Ghaffari M; McCormack RG; Duronio V
J Physiol; 2016 Jun; 594(11):2971-83. PubMed ID: 26670924
[TBL] [Abstract][Full Text] [Related]
7. Safety, tolerability and pharmacokinetics of liposomal curcumin in healthy humans.
Storka A; Vcelar B; Klickovic U; Gouya G; Weisshaar S; Aschauer S; Bolger G; Helson L; Wolzt M
Int J Clin Pharmacol Ther; 2015 Jan; 53(1):54-65. PubMed ID: 25500488
[TBL] [Abstract][Full Text] [Related]
8. p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines.
Moon SU; Kim JW; Sung JH; Kang MH; Kim SH; Chang H; Lee JO; Kim YJ; Lee KW; Kim JH; Bang SM; Lee JS
Cancer Res Treat; 2015 Jul; 47(3):501-8. PubMed ID: 25672581
[TBL] [Abstract][Full Text] [Related]
9. A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.
Tate CM; Mc Entire J; Pallini R; Vakana E; Wyss L; Blosser W; Ricci-Vitiani L; D'Alessandris QG; Morgante L; Giannetti S; Larocca LM; Todaro M; Benfante A; Colorito ML; Stassi G; De Maria R; Rowlinson S; Stancato L
PLoS One; 2015; 10(4):e0125697. PubMed ID: 25919028
[TBL] [Abstract][Full Text] [Related]
10. Curcumin sensitizes human lung cancer cells to apoptosis and metastasis synergistically combined with carboplatin.
Kang JH; Kang HS; Kim IK; Lee HY; Ha JH; Yeo CD; Kang HH; Moon HS; Lee SH
Exp Biol Med (Maywood); 2015 Nov; 240(11):1416-25. PubMed ID: 25716014
[TBL] [Abstract][Full Text] [Related]
11. RGS16, a novel p53 and pRb cross-talk candidate inhibits migration and invasion of pancreatic cancer cells.
Carper MB; Denvir J; Boskovic G; Primerano DA; Claudio PP
Genes Cancer; 2014 Nov; 5(11-12):420-35. PubMed ID: 25568667
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues.
Li Q; Chen J; Luo S; Xu J; Huang Q; Liu T
Eur J Med Chem; 2015 Mar; 93():461-9. PubMed ID: 25728027
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the NF-κB signaling pathway by a novel heterocyclic curcumin analogue.
Katsori AM; Palagani A; Bougarne N; Hadjipavlou-Litina D; Haegeman G; Vanden Berghe W
Molecules; 2015 Jan; 20(1):863-78. PubMed ID: 25580684
[TBL] [Abstract][Full Text] [Related]
14. Advances in the treatment of pancreatic cancer with traditional Chinese medicine.
Zhang Y; Xu H; Li Y; Sun Y; Peng X
Front Pharmacol; 2023; 14():1089245. PubMed ID: 37608897
[TBL] [Abstract][Full Text] [Related]
15. Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy.
Huang M; Zhai BT; Fan Y; Sun J; Shi YJ; Zhang XF; Zou JB; Wang JW; Guo DY
Int J Nanomedicine; 2023; 18():4275-4311. PubMed ID: 37534056
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases.
Sadeghi M; Dehnavi S; Asadirad A; Xu S; Majeed M; Jamialahmadi T; Johnston TP; Sahebkar A
Inflammopharmacology; 2023 Jun; 31(3):1069-1093. PubMed ID: 36997729
[TBL] [Abstract][Full Text] [Related]
17. The anticancer effects of curcumin and clinical research progress on its effects on esophageal cancer.
Wang S; Gao X; Li J; Wei S; Shao Y; Yin Y; Zhang D; Tang M
Front Pharmacol; 2022; 13():1058070. PubMed ID: 36386215
[TBL] [Abstract][Full Text] [Related]
18. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer.
Sudhesh Dev S; Zainal Abidin SA; Farghadani R; Othman I; Naidu R
Front Pharmacol; 2021; 12():772510. PubMed ID: 34867402
[TBL] [Abstract][Full Text] [Related]
19. Antimetastatic Effects of Curcumin in Oral and Gastrointestinal Cancers.
Davoodvandi A; Farshadi M; Zare N; Akhlagh SA; Alipour Nosrani E; Mahjoubin-Tehran M; Kangari P; Sharafi SM; Khan H; Aschner M; Baniebrahimi G; Mirzaei H
Front Pharmacol; 2021; 12():668567. PubMed ID: 34456716
[TBL] [Abstract][Full Text] [Related]
20. Perspectives for synthetic curcumins in chemoprevention and treatment of cancer: An update with promising analogues.
Adeluola A; Zulfiker AHM; Brazeau D; Amin ARMR
Eur J Pharmacol; 2021 Sep; 906():174266. PubMed ID: 34146588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
